Enliven Therapeutics, Inc. (ELVN)
Market Open
1 Sep, 19:43
NASDAQ (NGS) NASDAQ (NGS) Primary $
58. 07
+0.18
+0.3109%
$
4.14B Market Cap
- P/E Ratio
- Div Yield
871,691 Volume
-2.36 Eps
$ 57.89
Previous Close 
Want to track ELVN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Enliven Therapeutics, Inc. (ELVN) Statistics
Valuation metrics
Market Cap 4.14B
Enterprise value 4B
Trailing P/E (ttm) -35.28
Forward P/E -
PEG ratio -1.78
Price/Sales (ttm) -
Price/Book (mrq) 4.28
Enterprise Value/Revenue -
Enterprise Value/EBITDA -37.8
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 584.96K
Average volume (90 days) 1.97M
Price summary
52-Week low 14.79
52-Week high 62.32
Beta -
50-Day moving average 57.34
200-Day moving average 39.82
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:4
Last split Date 24 Feb 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.12%
Return on equity -0.19%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.6
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 13.53
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 64.07%
Book value per share (mrq) 13.53
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
